What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
Year: 2009
Type: review
Source: Current Opinion in Lipidology
Authors: Harold E Bays, Christie Ballantyne
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W2068615855
